ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)

ClinicalTrials.gov ID: NCT06636786

Public ClinicalTrials.gov record NCT06636786. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL) - (Optimizing Acute Stress Reaction Interventions With TNX-102 SL - OASIS)

Study identification

NCT ID
NCT06636786
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of North Carolina, Chapel Hill
Other
Enrollment
180 participants

Conditions and interventions

Interventions

  • Cyclobenzaprine HCl Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 24, 2025
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026
Last update posted
Apr 12, 2026

2025 – 2026

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 Not yet recruiting
Indiana University Indianapolis Indiana 46202 Recruiting
University of Kansas Medical Center Kansas City Kansas 66160 Recruiting
Washington University in St. Louis St Louis Missouri 63110 Recruiting
Cooper University Health System Camden New Jersey 08103 Recruiting
The Ohio State University Columbus Ohio 43210 Recruiting
Rhode Island Hospital Providence Rhode Island 02903 Recruiting
The Miriam Hospital Providence Rhode Island 02903 Recruiting
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06636786, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06636786 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →